Evidence map›Paper›PMID 38051272›Full record

ArticleACS nano2023

Pulmonary Toxicity of Boron Nitride Nanomaterials Is Aspect Ratio Dependent.

Luis Augusto Visani de Luna, Thomas Loret, Yilin He, Morgan Legnani, Hazel Lin, Anne Marie Galibert, Alexander Fordham, Sonja Holme, Antonio Esau Del Rio Castillo, Francesco Bonaccorso and 4 more

Open access · hybridAbstract read
In one paragraph

Article in ACS nano, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 4 countries.

Luis Augusto Visani de LunaNanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
Thomas LoretNanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
Yilin HeCNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, 67000 Strasbourg, France.
Morgan LegnaniCIRIMAT, Université Toulouse 3 Paul Sabatier, Toulouse INP, CNRS, Université de Toulouse, 118 Route de Narbonne, 31062 Toulouse cedex 9, France.
Hazel LinCNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, 67000 Strasbourg, France.
Anne Marie GalibertCIRIMAT, Université Toulouse 3 Paul Sabatier, Toulouse INP, CNRS, Université de Toulouse, 118 Route de Narbonne, 31062 Toulouse cedex 9, France.
Alexander FordhamNanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
Sonja HolmeNanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.
Antonio Esau Del Rio CastilloBeDimensional S.p.A., Lungo Torrente Secca 30r, 16163 Genoa, Italy.
Francesco BonaccorsoBeDimensional S.p.A., Lungo Torrente Secca 30r, 16163 Genoa, Italy.
Alberto BiancoCNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, University of Strasbourg, ISIS, 67000 Strasbourg, France.ORCID 0000-0002-1090-296X
Emmanuel FlahautCIRIMAT, Université Toulouse 3 Paul Sabatier, Toulouse INP, CNRS, Université de Toulouse, 118 Route de Narbonne, 31062 Toulouse cedex 9, France.ORCID 0000-0001-8344-6902
Kostas KostarelosNanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.ORCID 0000-0002-2224-6672
Cyrill BussyNanomedicine Lab, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PT, U.K.ORCID 0000-0001-8870-443X
Centre National de la Recherche Scientifique · FRManchester Academic Health Science Centre · GBBeDimensional (Italy) · ITItalian Institute of Technology · IT

Funding

Wellcome Trust
6 · The paper itself

Abstract

Boron nitride (BN) nanomaterials have drawn a lot of interest in the material science community. However, extensive research is still needed to thoroughly analyze their safety profiles. Herein, we investigated the pulmonary impact and clearance of two-dimensional hexagonal boron nitride (

Indexed as

NanostructuresNanotubes, CarbonAnimalsBoron CompoundsLungMiceBoron Compoundsboron nitrideNanotubes, Carbon2D materialsclearancefibrosisgenotoxicityinflammationlungsnanotubes

Identifiers

PMID38051272
PMCPMC10753895
OpenAlexW4389348947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.